Biomedical Modeling Overview

Principles

Definition

Biomedical modeling is a research field employing computational and mathematical techniques to simulate, analyze, and predict the behavior of biological systems across various scales, from molecular interactions to organ-level function. This methodological approach is critical for enhancing the understanding of health and disease mechanisms, developing novel diagnostics and therapies, and advancing personalized medicine.

Ontological type

Core Methods

Clinical Applications

Model Validation

Key developments

Key Figures

Foundational Multiscale Modeling era

H. Eugene Stanley [1] is associated with Harvard University [3] and the Massachusetts Institute of Technology [4] in this Foundational Multiscale Modeling era. His key contribution includes the 2002 paper Fractal dynamics in physiology: Alterations with disease and aging [7], which demonstrated fractal patterns in physiology across scales and their changes with disease and aging, underscoring the multiscale framework of this era. Alexander R.A. Anderson [2] is associated with the University of Dundee [5] and the University of Glasgow [6] in this era. His contributions include the 1998 paper Continuous and Discrete Mathematical Models of Tumor-induced Angiogenesis [8] and the 1999 paper Mathematical Modelling of Tumour Invasion and Metastasis [9], which advanced quantitative modeling of tumor growth and spread and established essential links between cellular processes and tissue-level behaviors.

Translational Multiscale Integration era

Matthew Meyerson [1], affiliated with the Harvard–MIT Division of Health Sciences and Technology [3] and Harvard University [4], contributed to translational multiscale modeling in this era. His key contribution in this era, exemplified by The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [5], was to provide a large-scale pharmacogenomic resource that links genomic features to drug responses, enabling predictive modeling and informing translational decision-making. Gad Getz [2], also affiliated with the Harvard–MIT Division of Health Sciences and Technology [3] and Harvard University [4], helped advance the same translational aims during this era. His key contribution, centered on The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [5], established a comprehensive catalog of cancer cell line genomics and drug sensitivity data, essential for uncovering molecular determinants of response and enabling patient-relevant predictions in translational multiscale modeling.

Digital Twin Biomechanics era

Bernhard Ø. Palsson[1] is a leading figure in systems biology associated with University of California, San Diego[3] and Technical University of Denmark[4] during the Digital Twin Biomechanics era. His key contribution in this era is the creation and analysis of biochemical constraint-based models as described in the paper Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0[7], enabling rapid, standardized metabolic predictions and informing constraint-based simulations. Costas D. Maranas[2] is a prominent researcher linked with Park University[5] and Peking University[6] during this era. His key contributions center on the creation and analysis of biochemical constraint-based models as described in the paper Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0[7], which standardized constraint-based modeling and empowered data-informed metabolic analyses within data-augmented, physics-informed workflows.